GPR43/FFA2: physiopathological relevance and therapeutic prospects.

[1]  Patrice D Cani,et al.  Evaluation of the relationship between GPR43 and adiposity in human , 2013, Nutrition & Metabolism.

[2]  B. Hudson,et al.  Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  W. D. de Vos,et al.  Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women , 2012, Gut.

[4]  B. Hudson,et al.  Extracellular Ionic Locks Determine Variation in Constitutive Activity and Ligand Potency between Species Orthologs of the Free Fatty Acid Receptors FFA2 and FFA3* , 2012, The Journal of Biological Chemistry.

[5]  T. Ulven.  Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets , 2012, Front. Endocrin..

[6]  O. Feron,et al.  Gut microbiota-derived propionate reduces cancer cell proliferation in the liver , 2012, British Journal of Cancer.

[7]  S. Offermanns,et al.  G protein-coupled receptors for energy metabolites as new therapeutic targets , 2012, Nature Reviews Drug Discovery.

[8]  F. Duca,et al.  Increased Oral Detection, but Decreased Intestinal Signaling for Fats in Mice Lacking Gut Microbiota , 2012, PloS one.

[9]  Brian K Shoichet,et al.  Structure-based drug screening for G-protein-coupled receptors. , 2012, Trends in pharmacological sciences.

[10]  D. Donnelly,et al.  The structure and function of the glucagon‐like peptide‐1 receptor and its ligands , 2012, British journal of pharmacology.

[11]  A. M. Habib,et al.  Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2 , 2012, Diabetes.

[12]  M. Gänzle,et al.  Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats , 2012, British Journal of Nutrition.

[13]  R. Curi,et al.  Regulation of Inflammation by Short Chain Fatty Acids , 2011, Nutrients.

[14]  Jacques Schrenzel,et al.  Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice , 2011, Diabetes.

[15]  J. Olefsky,et al.  Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. , 2011, Trends in pharmacological sciences.

[16]  L. Deldicque,et al.  Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. , 2011, The Journal of nutritional biochemistry.

[17]  Patrice D Cani,et al.  Interaction between obesity and the gut microbiota: relevance in nutrition. , 2011, Annual review of nutrition.

[18]  Leigh A. Stoddart,et al.  Extracellular Loop 2 of the Free Fatty Acid Receptor 2 Mediates Allosterism of a Phenylacetamide Ago-Allosteric Modulator , 2011, Molecular Pharmacology.

[19]  P. Hawkins,et al.  SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor , 2011, PloS one.

[20]  M. Noakes,et al.  Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. , 2011, The Journal of nutrition.

[21]  D. Nie,et al.  Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death , 2011, Cell Death and Differentiation.

[22]  D. Nie,et al.  G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer , 2011, International journal of cancer.

[23]  R. Lindberg,et al.  Mutational analysis of G-protein coupled receptor--FFA2. , 2011, Biochemical and biophysical research communications.

[24]  I. Kaji,et al.  Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide , 2011, Journal of Molecular Histology.

[25]  J. Darzi,et al.  Do SCFA have a role in appetite regulation? , 2011, Proceedings of the Nutrition Society.

[26]  B. Hudson,et al.  Selective Orthosteric Free Fatty Acid Receptor 2 (FFA2) Agonists , 2011, The Journal of Biological Chemistry.

[27]  R. Lindberg,et al.  Allosteric rescuing of loss‐of‐function FFAR2 mutations , 2010, FEBS letters.

[28]  Nathalie M. Delzenne,et al.  Prebiotic effects: metabolic and health benefits , 2010, British Journal of Nutrition.

[29]  M. Cawthorne,et al.  Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids , 2010, FEBS letters.

[30]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[31]  T. Wolever,et al.  The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[32]  S. Wong,et al.  The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. , 2010, Bioorganic & medicinal chemistry letters.

[33]  N. Sata,et al.  Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening , 2010, Cancer science.

[34]  F. Monsma,et al.  Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines. , 2009 .

[35]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[36]  T. Wolever,et al.  Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α , 2009, British Journal of Nutrition.

[37]  I. Rowland.  The role of the gastrointestinal microbiota in colorectal cancer. , 2009, Current pharmaceutical design.

[38]  T. van de Wiele,et al.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability , 2009, Gut.

[39]  Leigh A. Stoddart,et al.  International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions , 2008, Pharmacological Reviews.

[40]  Yang Li,et al.  Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2 , 2008, Molecular Pharmacology.

[41]  Leigh A. Stoddart,et al.  Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids* , 2008, Journal of Biological Chemistry.

[42]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[43]  Yang Li,et al.  Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. , 2008, Endocrinology.

[44]  I. Kaji,et al.  Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[45]  S. Karaki,et al.  Expression of the short-chain fatty acid receptor, GPR43, in the human colon , 2008, Journal of Molecular Histology.

[46]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[47]  W. Shehee,et al.  The relationship between the effects of short‐chain fatty acids on intestinal motility in vitro and GPR43 receptor activation , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[48]  T. Iwanaga,et al.  Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine , 2006, Cell and Tissue Research.

[49]  Ki-Choon Choi,et al.  Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. , 2005, Endocrinology.

[50]  R. Kedzierski,et al.  Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[52]  M. Parmentier,et al.  Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation* , 2003, Journal of Biological Chemistry.

[53]  B. Olde,et al.  Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. , 2003, Biochemical and biophysical research communications.

[54]  S. Dowell,et al.  The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* , 2003, The Journal of Biological Chemistry.

[55]  J. Galmiche,et al.  Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression , 2000, Gut.

[56]  E. Anderson.  Hudson et al. , 1977 .

[57]  B. Hudson,et al.  Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors. , 2011, Advances in pharmacology.

[58]  M. Bohlooly-y,et al.  Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. , 2011, American journal of physiology. Endocrinology and metabolism.

[59]  P. Rosenstiel,et al.  Inflammationfor Neutrophil Recruitment during Intestinal G Protein-Coupled Receptor 43 Is Essential , 2009 .